Most Recent
Class action firms circle Cochlear over $4B market cap dive
Hearing implant giant Cochlear faces a second shareholder class action following two forecast downgrades that wiped billions of dollars from the company's market value.
AI use in class actions hailed, but where do junior lawyers fit in?
Lawyers have welcomed a judge's orders that AI be used in class actions to improve efficiency, but warned it could remove opportunities for junior solicitors to hone necessary skills. 
Lawyers, funder to seek 75% of AMP’s $29M class action settlement
The lawyers and funder behind a settled class action against AMP will ask a court to OK fees and commission totalling almost $22 million, a bill that leaves just $7 million for group members but represents a $43 million loss on actual costs.
Class action fights Worley’s High Court appeal, says proof ‘overwhelming’
A shareholder class action that succeeded in the Full Federal Court has argued that Worley's appeal to the High Court should be rejected, saying that its proof regarding market-based causation was “overwhelming”.
Group members to get just 23% in ‘likely to fail’ CommInsure class action 
A judge has approved a $22.5 million settlement in a class action against two former CBA wealth management units, under which group members will receive just $5.12 million and the lawyers and funder will receive the lion’s share.
Law firm investigates Meta class action after US settlement
Meta is facing a class action investigation after reaching a multibillion-dollar settlement in cases by US authorities alleging the company designed its social media platforms to increase the risk of addiction.
Blue Sky class action judge mulls AI fix after costs reach $20M
A judge overseeing a shareholder class action over the collapse of fund manager Blue Sky will explore how artificial intelligence can be used to reduce costs in the case, which have already reached $20 million.
Judge suggests hearing GCO bid in J&J class action after defence
A judge has suggested there may be merit in waiting for Johnson & Johnson to file a defence before deciding an application for a group costs order in a class action accusing the company of selling defective, carcinogenic talcum powder.
Mid-trial amendment in Nuix class action wins court OK
A judge has allowed a mid-trial amendment in a shareholder class action over software company Nuix's 2020 public float on the ASX.
Nuix slams ‘late and defective’ proposed mid-trial amendment
Nuix has blasted as defective and "exceptionally" late a proposed mid-trial amendment to the pleadings in a shareholder class action over the software firm's 2020 IPO.